. Author manuscript; available in PMC: 2022 Apr 20.

Published in final edited form as: Mult Scler Relat Disord. 2021 Aug 2;55:103185. doi: 10.1016/j.msard.2021.103185

Table 1:

Study Cohorts and Age at Exam

Source	Race	Gender	MS Type	N	Age at Exam
VALOMS	AA	Male	RR	13	44.6 ± 2.4
			SP	7	43.7 ± 4.1 ^a
		Female	RR	8	41.1 ± 3.0
			SP	5	48.0 ± 4.5
	White	Male	RR	24	48.7 ± 2.1
			SP	21	52.5 ± 1.5 ^b
		Female	RR	6	42.8 ± 2.8 ^c
			SP	7	52.6 ± 1.6
ACP	AA	Male	RR	17	40.4 ± 2.7
ACP		Female	RR	92	42.3 ± 1.1
UCSF	White	Male	RR	209	46.0 ± 0.8
UCSF		Female	RR	445	47.0 ± 2.2
ACP	AA	Male	Control	11	49.9 ± 4.1
ACP		Female	Control	31	46.9 ± 3.1
UCSF	AA	Male	Control	100	45.3 ± 1.1
UCSF		Female	Control	298	43.5 ± 0.6
ACP & UCSF	AA	Male	Control	111	45.8 ± 1.1
ACP & UCSF		Female	Control	329	43.8 ± 0.6
UCSF	White	Male	Control	236	44.5 ± 0.9
UCSF		Female	Control	425	42.6 ± 0.6

^a,

P<0.05 versus VA White male SPMS

^b,

P<0.05 versus UCSF White male RRMS

^c,

P<0.05 versus VA White female SPMS. Data is mean ± se. AA, African American; ACP, Accelerated Cure Project; RR, relapsing remitting; SP, secondary progressive.